🇺🇸 FDA

Intelligence Platform

Patents

Browse 401 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11771745

Compositions and methods for treatment of homocystinuria

The Regents of the University of Colorado · Granted Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11738022

Methods for inducing pupil dilation

The Regents of the University of Colorado, a Body Corporate · Granted Tue Aug 29 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11701361

p110-delta inhibitors treat and prevent autoimmunity while sparing the ability to mount an

The Regents of the University of Colorado · Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11679093

2-naphthimidamides, analogues thereof, and methods of treatment using same

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11642319

Targeted nanogels for urinary bladder therapies

The Regents of the University of Colorado · Granted Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11613502

Core-shell ceramic particle colloidal gel and solid oxide fuel cell electrolyte

The Regents of the University of Colorado · Granted Tue Mar 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11602556

Insulin mimotopes and methods of using the same

The Regents of the University of Colorado, a Body Corporate · Granted Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11572588

Methods of evaluating treatment efficacy and/or treatment duration in mycobacterial diseas

The Regents of the University of Colorado, a Body Corporate · Granted Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11566242

Methods and compositions for reprogramming cells

The Regents of the University of Colorado, a Body Corporate · Granted Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11534429

Small molecule inhibitors of bacterial efflux pumps and methods of using same

The Regents of the University of Colorado · Granted Tue Dec 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11524985

IL-37 fusion protein and methods of making and using same

The Regents of the University of Colorado · Granted Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 08 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11497770

Compositions and methods for treating cancer with TSLPR-CD19 or TSLPR-CD22 immunotherapy

The Regents of the University of Colorado · Granted Tue Nov 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11491111

Thermostable vaccine compositions and methods of preparing same

The Regents of the University of Colorado, a Body Corporate · Granted Tue Nov 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11479772

Thiomorpholino oligonucleotides for the treatment of muscular dystrophy

The Regents of the University of Colorado · Granted Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11472812

Anti-cancer compounds targeting Ral GTPases and methods of using the same

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11471496

Compositions and methods for treating or ameliorating cocaine addiction

The Regents of the University of Colorado · Granted Tue Oct 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11466010

Toll-like receptor 8 (TLR8) specific antagonists and methods of making and uses thereof

The Regents of the University of Colorado, a Body Corporate · Granted Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11459560

Methods and compositions for reprogramming cells

The Regents of the University of Colorado · Granted Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11452709

Compositions and methods for preventing and treating radiation-induced bystander effects c

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11433038

High concentration medicant solutions for treating neurological disorders

The Regents of the University of Colorado · Granted Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11433126

Protection from stress, anxiety, neuroinflammation, and cognitive dysfunction

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11433088

Methods for treatment of vascular endothelial dysfunction using nicotinamide mononucleotid

The Regents of the University of Colorado, a Body Corporate · Granted Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11426409

Compounds, compositions and methods for treating or preventing HER-driven drug-resistant c

The Regents of the University of Colorado · Granted Tue Aug 30 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 25 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11407820

Modulating the alternative complement pathway

The Regents of the University of Colorado · Granted Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted